CD47 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD47 monoclonal antibodies for investigating CD47's role in various biological processes. CD47 monoclonal antibodies are compatible with multiple research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD47, known as the "don't eat me" signal, plays a critical role in regulating immune responses by inhibiting phagocytosis. CD47 expression is associated with various physiological and pathological processes, including cancer progression and immune evasion. Understanding CD47 function is essential for developing therapeutic strategies in diseases such as cancer and autoimmune disorders. CD47 research continues to reveal new insights into immune system regulation and cellular signaling pathways. Ongoing studies of CD47 are uncovering potential therapeutic applications in cancer immunotherapy and autoimmune disease treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CD47's role in human health and disease.